ESMO 2025 Industry Satellite Symposium
BRAF mutations: Evolving treatment paradigms across tumour types
Join us as we discuss the evolving landscape of BRAF mutation-targeted treatment in melanoma, lung, and colorectal cancer.
CAST YOUR VOTE
Saturday, 18 October 2025 | 18:30 – 20:00 (CEST)
Koblenz Auditorium – Hall 5.2, Messe Berlin, Germany
Watch the symposium chair, Prof. Sebastian Stintzing, share his insights and set the stage for an inspiring and thought‑provoking event
Meet the experts
Sebastian Stintzing
Charité University Hospital, Berlin, Germany
Frédérique Penault-Llorca
University of Clermont-Ferrand, France
Elena Elez
Vall d’Hebron Institute of Oncology, Barcelona, Spain
Federico Cappuzzo
National Cancer Institute Regina Elena, Rome, Italy
Dirk Schadendorf
University Medicine Essen, Germany
Agenda
Welcome and introductions
Sebastian Stintzing
Personalising the future:
The next chapter in the treatment of BRAF-mutant cancers
Sebastian Stintzing
Breaking barriers in molecular testing for BRAF mutations
Frédérique Penault-Llorca
Treatment strategies in BRAFV600E-mutant mCRC:
The right treatment for the right patient
Elena Elez
Integrating emerging evidence into the care of patients with BRAFV600E-mutant advanced NSCLC
Federico Cappuzzo
Advancing care in BRAFV600-mutant metastatic melanoma:
Harnessing real-world evidence to personalise care
Dirk Schadendorf
Panel discussion/interactive session
All
Closing
Sebastian Stintzing
Have your say in the panel discussion
Help shape the conversation during the interactive session.
Your voice matters in shaping the symposium program. We invite you to participate by selecting the topic you're most interested in, to be featured in the upcoming panel discussion.
This non-promotional event is organised and funded by Pierre Fabre and is intended for HCPs only